{"id":"W1949811104","doi":"10.1200/jco.2001.19.2.314","title":"Phase II Study of Docetaxel, Doxorubicin, and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer","year":2001,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"ca_institutions":"Saskatchewan Cancer Agency","funders":"","keywords":"Medicine; Docetaxel; Metastatic breast cancer; Neutropenia; Cyclophosphamide; Febrile neutropenia; Internal medicine; Chemotherapy; Doxorubicin; Regimen; Breast cancer; Surgery; Phases of clinical research; Gastroenterology; Adverse effect; Cancer; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001338209,0.0001746006,0.001856676,0.000118996,0.00006913643,0.000003621019,0.0001053504,0.0001466273,0.0008294496],"category_scores_gemma":[0.0003267361,0.0001185791,0.0003177255,0.000157915,0.0001741497,0.00007991251,0.00003165809,0.0003933718,0.000001498448],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001087144,"about_ca_system_score_gemma":0.0007738406,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002356747,"about_ca_topic_score_gemma":0.0004052944,"domain_scores_codex":[0.9972617,0.0001460077,0.001930939,0.0002069315,0.0002253716,0.0002290281],"domain_scores_gemma":[0.9959768,0.001553256,0.001531586,0.0001310249,0.0004786811,0.0003286214],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1253214,0.1134796,0.1063086,0.0001294249,0.005267639,0.001072254,0.001242392,0.0000573147,0.001399369,0.00002989401,0.01284228,0.6328498],"study_design_scores_gemma":[0.312093,0.4047886,0.09182341,0.0001345754,0.005389199,0.002310494,0.0005291697,0.0001953001,0.0005757895,0.0006836724,0.1812679,0.00020879],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9738836,0.002182744,0.00005204931,0.02196096,0.0008734156,0.0007668308,0.00002254632,0.000006385672,0.000251439],"genre_scores_gemma":[0.9831141,0.01069147,0.0006366586,0.003667286,0.001105358,0.00003377902,0.000002568927,0.00002119593,0.0007276441],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.632641,"threshold_uncertainty_score":0.9081892,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1341035759241524,"score_gpt":0.5424805441816323,"score_spread":0.4083769682574799,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}